FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to a method for detecting the synchronous tumour growth in the male patients suffering colon cancer. Substance of the invention consists in measuring preoperative blood testosterone and intestinal cell-stimulating hormone by Immunotech test systems (Czech Republic) in the male patients suffering colon cancer. Testosterone/intestinal cell-stimulating hormone ratio is calculated; if the derived value falls within the range of 0.45-2.18 enables stating the presence of single colon cancer, while the values within the range of 0.03-0.38 provides stating the presence of synchronous tumours.
EFFECT: using the declared method enables the more accurate preoperative detection of single or synchronous growth in the given category of patients.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF SYNCHRONOUS MULTIFOCAL COLORECTAL CARCINOMA | 2013 |
|
RU2539389C1 |
METHOD FOR ADJUVANT CHEMOTHERAPY DURATION DETERMINATION IN CASE OF LOCALLY ADVANCED COLORECTAL CANCER WITH METASTASES IN REGIONAL LYMPH NODES AFTER RADICAL SURGERY | 2015 |
|
RU2618405C1 |
METHOD FOR LOCAL-DISTRIBUTED COLON CANCER METASTASIS | 2016 |
|
RU2619340C1 |
METHOD FOR PREDICTION OF DEVELOPING METASTASES IN PATIETNS SUFFERING RECTAL CANCER | 2009 |
|
RU2420742C1 |
METHOD FOR DISTANT METASTASES DEVELOPMENT RISK DEGREE DETERMINATION FOR PATIENTS WITH COLON CANCER | 2016 |
|
RU2623119C1 |
METHOD FOR COLORECTAL CANCER METASTASES DIAGNOSTICS IN LIVER | 2016 |
|
RU2642247C1 |
METHOD FOR PREDICTING METASTASIS IN COLON CANCER | 2015 |
|
RU2613142C1 |
METHOD FOR DIAGNOSING METASTASES OF COLON CANCER | 2016 |
|
RU2647470C2 |
METHOD FOR TREATING METASTASES OF COLORECTAL CANCER IN THE LIVER | 2017 |
|
RU2663800C2 |
METHOD FOR DETERMINING INDICATIONS FOR REMOVAL OF PRIMARY TUMOUR IN PATIENT WITH SYNCHRONOUS DISTANT METASTASES OF COLORECTAL CANCER IN PRESENCE OF INTESTINAL OBSTRUCTION | 2023 |
|
RU2818550C1 |
Authors
Dates
2015-04-10—Published
2013-05-14—Filed